欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | CANCER CELL CANCER CELL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 9.8
51人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.4 | |||||||||||||||||||||||||||||||
期刊ISSN | 1535-6108 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||||||||||||
E-ISSN | 1878-3686 | |||||||||||||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 44.5 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:44.264 | |||||||||||||||||||||||||||||||
2024-2025自引率 | 1.30%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 47.2 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 8.11 | |||||||||||||||||||||||||||||||
h-index | 295 | |||||||||||||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://www.cell.com/cancer-cell/home | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/CANCER-CELL | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER CELL的语言要求,还能让CANCER CELL编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER CELL编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | CELL PRESS, 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||||||||||||
出版商 | Cell Press | |||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||||||||
出版年份 | 2002 | |||||||||||||||||||||||||||||||
年文章数 | 112点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 42.81% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 93.75% | |||||||||||||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-6108%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 偏慢,4-8周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 极难 | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在CANCER CELL顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion Author: Zhu, Yinghua; Zhou, Ziwei; Du, Xin; Lin, Xiaorong; Liang, Zhi-Mei; Chen, Si; Sun, Yiwei; Wang, Yue; Na, Zhenkun; Wu, Zhiyong; Zhong, Jiaxin; Han, Beinan; Zhu, Xiangping; Fu, Wenkui; Li, Hongde; Luo, Man-Li; Hu, Hai Journal: CANCER CELL. 2025; Vol. 43, Issue 6, pp. -. DOI: 10.1016/j.ccell.2025.03.015 PubMed DOI |
2. | Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures Author: Tang, Zhonghui; Bai, Yinqi; Fang, Qi; Yuan, Yuchen; Zeng, Qianwen; Chen, Shuling; Xu, Tianyi; Chen, Jianyu; Tan, Li; Wang, Chunqing; Li, Qian; Lin, Jinpei; Yang, Zhuoxuan; Wu, Xia; Shi, Guowei; Wang, Ji; Yin, Changjun; Guo, Jianping; Liu, Shiping; Peng, Sui; Kuang, Ming Journal: CANCER CELL. 2025; Vol. 43, Issue 6, pp. -. DOI: 10.1016/j.ccell.2025.03.011 PubMed DOI |
3. | A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies Author: Mosialou, Ioanna; Ali, Abdullah M.; Labella, Rossella; Bisikirska, Brygida; Cuesta-Dominguez, Alvaro; Vgenopoulou, Paraskevi; Reyes, Ismarc; Rao, Sanjana M.; Wang, Anqi; Luo, Na; Galan-Diez, Marta; Zhao, Junfei; Chernak, Brian J.; Bewersdorf, Jan Philipp; Fukasawa, Kazuya; Su, Jiayu; Higa, Jason; Adams, Rachel A.; Corper, Adam L.; Pampou, Sergey; Woods, Catherine M.; Fan, Xiaomin; Shah, Roshan P.; Feldstein, Julie; Liu, Na; Liang, Cui; Heiblig, Mael; Kornblau, Steven; Garcia-Manero, Guillermo; Berman, Ellin; Jurcic, Joseph G.; Rabadan, Raul; Raza, Azra; Kousteni, Stavroula Journal: CANCER CELL. 2025; Vol. 43, Issue 6, pp. -. DOI: 10.1016/j.ccell.2025.03.007 PubMed DOI |
4. | Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer Author: Ma, Ding; Dai, Lei-Jie; Wu, Xiang-Rong; Liu, Cheng-Lin; Zhao, Shen; Zhang, Hang; Chen, Li; Xiao, Yi; Li, Ming; Zhao, Yi-Zhi; Yang, Lin; Zhou, Tong; Li, Jun-Jie; Yang, Wen-Tao; Jiang, Yi-Zhou; Shao, Zhi-Ming Journal: CANCER CELL. 2025; Vol. 43, Issue 6, pp. -. DOI: 10.1016/j.ccell.2025.03.017 PubMed DOI |
5. | Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts Author: Cheng, Jia-Nan; Jin, Zheng; Su, Chunxia; Jiang, Tao; Zheng, Xiaobin; Guo, Jinming; Li, Xingyi; Chu, Han; Jia, Jia; Zhou, Qin; Ding, Xiaofang; Zhang, Yiwen; Xu, Shouxia; Dong, Fancong; Zhang, Qiao; Yang, Xinxin; Yang, Tao; Cheng, Xiaoming; Zha, Haoran; Chen, Degao; Wan, Yisong Y.; Liu, Xindong; Ye, Lilin; Tang, Haidong; Symonds, Alistair L. J.; Li, Qi-Jing; Jia, Qingzhu; Zhu, Bo Journal: CANCER CELL. 2025; Vol. 43, Issue 6, pp. -. DOI: 10.1016/j.ccell.2025.03.036 PubMed DOI |
6. | Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial Author: Xu, Cheng; Zhou, Guan-Qun; Li, Wen-Fei; Hu, De-Sheng; Chen, Xiao-Zhong; Lin, Shao-Jun; Jin, Feng; Huang, Xin-Qiong; Peng, Gang; Huang, Jing; Wu, Yuan; Tao, Chang-Juan; Li, Ji-Bin; Lin, Ai-Hua; Zhao, Hong-Yun; Hong, Shu-Bin; Huang, Hui-Ling; Tang, Ling-Long; Peng, Ying-Lin; Shi, Ke-Fu; Chen, Liu; Qi, Li-Ping; Yang, Kun-Yu; Shen, Liang-Fang; Sun, Ying; Ma, Jun Journal: CANCER CELL. 2025; Vol. 43, Issue 5, pp. -. DOI: 10.1016/j.ccell.2025.01.014 PubMed DOI |
7. | Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation Author: Teng, Mona; Guo, Jiacheng; Xu, Xin; Ci, Xinpei; Mo, Yulin; Kohen, Yakup; Ni, Zuyao; Chen, Sujun; Guo, Wang Yuan; Bakht, Martin; Ku, Shengyu; Sigouros, Michael; Luo, Wenqin; Macarios, Colette Maya; Xia, Ziting; Chen, Moliang; Ul Haq, Sami; Yang, Wen; Berlin, Alejandro; van der Kwast, Theo; Ellis, Leigh; Zoubeidi, Amina; Zheng, Gang; Ming, Jie; Wang, Yuzhuo; Cui, Haissi; Lok, Benjamin H.; Raught, Brian; Beltran, Himisha; Qin, Jun; He, Housheng Hansen Journal: CANCER CELL. 2025; Vol. 43, Issue 5, pp. -. DOI: 10.1016/j.ccell.2025.03.027 PubMed DOI |
8. | Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma Author: An, Xin; Guo, Sheng Jie; Yan, Ru; Xue, Ting; Xiong, Long Bin; Ma, Hua Li; Xue, Cong; Zhang, Ying Chun; Bin Li, Ji; Chen, Mei Ting; Li, Zai Shang; Liu, Ting Yu; Zhang, Zhi Ling; Dong, Pei; Li, Yong Hong; Yao, Kai; Hu, Zhi Quan; Chen, Xiao Feng; Luo, Jie Xin; Lei, Yong Hong; Liang, Pei Yu; Liu, Zhi Zhong; Qi, Lin; Xu, Wen Feng; Cao, Zheng Guo; Chen, Nan Hui; Li, Xiang; Sheng, Xi Nan; Luo, Guang Heng; Shi, Ben Kang; Xie, Qun; Liu, Zhuo Wei; Zhou, Fang Jian; Spiess, Philippe E.; Shi, Yan Xia; Han, Hui Journal: CANCER CELL. 2025; Vol. 43, Issue 5, pp. -. DOI: 10.1016/j.ccell.2025.03.023 PubMed DOI |
9. | Global alliances in translational cancer research Author: Luo, Hui-Yan; Lu, Yun-Xin; Shitara, Kohei; Lenz, Heinz-Josef; Xu, Rui-Hua Journal: CANCER CELL. 2025; Vol. 43, Issue 4, pp. 581-586. DOI: 10.1016/j.ccell.2025.02.005 PubMed DOI |
10. | CAR-T therapy in solid tumors Author: Du, Bing; Qin, Juliang; Lin, Boxu; Zhang, Jiqin; Li, Dali; Liu, Mingyao Journal: CANCER CELL. 2025; Vol. 43, Issue 4, pp. 665-679. DOI: 10.1016/j.ccell.2025.03.019 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室